Corporate social responsibility in countries with mature and emerging pharmaceutical sectors

Pharmacy Practice

Volumn 7, Issue 4, 2009, Pages 228-237

  Volodina, Anna ^a   Sax, Sylvia ^a   Anderson, Stuart ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Drug Industry; Germany; Russia; Social Responsibility

Indexed keywords

ADVERTIZING; ARTICLE; CLINICAL PRACTICE; DEVELOPING COUNTRY; DRUG INDUSTRY; GERMANY; KNOWLEDGE; MEDICAL STUDENT; ORGANIZATION AND MANAGEMENT; PHARMACY STUDENT; RUSSIAN FEDERATION; SOCIAL BEHAVIOR; STUDENT ATTITUDE;

EID: 73649091479     PISSN: None     EISSN: 18863655     Source Type: Journal    
DOI: 10.4321/S1886-36552009000400006     Document Type: Article

References (27)

1. Final Report: Final results and recommendations. European Multi Stakeholder Forum on Corporate Social Responsibility. [place, publisher, date unknown]. May 2004 [cited 2008 May 26]. 27 p. Available at: http://circa.europa. eu/irc/empl/csr-eu-multi-stakeholder-forum/info/data/en/ CSR%20Forum%20final%20report.pdf
2. Kilcullen M, Kolstra JO. At least do no harm: sources on the changing role of business ethics and corporate social responsibility. Ref Serv Rev. 1999;27(2):158.
3. Maignan I, Ferrell OC. Corporate social responsibility and marketing: an integrative framework. J Acad Mark Sci. 2006;34(2):158-166.
4. Palazzo G, Richter U. CSR business as usual? The case of the tobacco industry. J Business Ethics. 2005;61:387-401.
5. Hirschhorn N. Corporate Social responsibility and the tobacco industry: hope or hype? Tobacco Contr. 2004;13:447-453.
6. Barraclough S, Morrow M. A grim contradiction: the practice and consequences of corporate social responsibility by British American Tobacco in Malaysia. Soc Sci Med. 2008;66 (8):1784-1796.
7. Givel M. Motivation of chemical industry corporate social responsibility through responsible care. Health Policy. 2007;81:85-92.
8. Dukes MNG. The law and ethics of the pharmaceutical industry. 2nd ed. London: Elsevier; c2005. Chapter 2.10: Corporate social responsibility and governments. pp. 109-123.
9. Esteban, D. Strengthening Corporate Social Responsibility in the Pharmaceutical Industry. J Med Mark. 2008;8(4):77-79.
10. Weyzig, F. (2004) Sector profile of the Pharmaceutical Industry. Amsterdam: Somo.
11. Single Market News (2000) The Lisbon Summit: Concrete Action to Stimulate European Competitiveness. Available at: http://ec.europa.eu/internal-market/ smn/smn21/s21mn14.htm (Accessed: 19 May 2008).
12. European Union Green Paper (2002) Promoting a European Framework for Corporate Social Responsibility. Available at: http://www.jussemper.org/ Resources/Corporate%20Activity/Resources/greenpaper-en.pdf (Accessed: 15 April 2008).
13. European Union White Paper (2002) Communication concerning Corporate Social Responsibility: A Business Contribution to Sustainable Development. Available at: http://www.jussemper.org/Resources/Corporate%20Activity/Resources/ sipade2.pdf (Accessed: 17 April 2008).
14. Mshvelidse, E. Investment in the Future. Pharm Rep. 2006;21(426):13-15.
15. Pharmacy reporter. Philanthropy in the pharmaceutical market. Pharm Rep. 2006a;21(4):29-30
16. Pharmacy reporter. Corporate Social Responsibility: what needs to be discussed. Pharm Rep. 2006b;11(62):2-4.
17. Latif DA, Berger BA. Moral reasoning in pharmacy students and community practitioners. J Soc Admin Pharm.. 1997;14(3):166-179
18. Anderson SC, Huss R, Summers R, Wiedenmayer K. Managing Pharmaceuticals in International Health. 2nd ed. Basel, Switzerland: Birkhauser; c2005. Chapter 4, Managing Pharmaceuticals in International Health: Policy Initiatives and their Implications; p. 156-169. Available at: http://www.hillandknowlton.com/ press/releases/2008/01/16/global-study-of-elite-mba-students (Accessed: 5 June 2008).
19. Freeman R, Liedtka, J. Corporate Social Responsibility: a Critical Approach. Business Horizons. 1991;34(4): 92-98.
20. United Nations Industrial Development Organization (UNIDO). Building linkages for Competitive and Responsible Entrepreneurship. [Internet]. 2007 [cited 2008 April 8] Available at: http://www.unido.org/fileadmin/import/69447- CSRI-08.pdf
21. European Union White Paper. Communication concerning Corporate Social Responsibility: A Business Contribution to Sustainable Development. [Internet]. 2002 [cited 2008 April 17] Available at: http://www.jussemper.org/Resources/ Corporate%20Activity/Resources/sipade2.pdf
22. Leisinger, K. Corporate Responsibility for Access to Medicines. Journal for Business Ethics; Feb 2009;85 (1):3-23.
23. European Union Green Paper. Promoting a European Framework for Corporate Social Responsibility. . [Internet]. 2002 [cited 2008 April 15] Available at: http://www.jussemper.org/Resources/Corporate%20Activity/Resources/greenpaper-en. pdf
24. Karima R, Oshima Y, Yamamoto K. Identification of subjects for Social Responsibility Education at Universities and the present activity of the University of Tokyo. Environ Sci.. 2006; 13 (6):327-337.
25. Dukes G. Accountability of the pharmaceutical industry. Lancet.. 2002;360 (1):1682-1684
26. Nissan, S. A Bitter Pill to Swallow? [date, publisher unknown]. Internet. [cited 2008 May 17] Available at: http://www.innovestgroup.com/pdfs/2003-08- 28bitter-pill.pdf
27. PricewaterhouseCoopers' Health Research Institute (2005) Recapturing the vision: Integrity driven performance in the pharmaceutical industry. London: PricewaterhouseCoopers LLP.